term. In addition to achieving revenue growth, the company-wide cost optimization is ongoing and translated into EBITDA expansion of +9% YoY and +2.4% QoQ to stand at Bt18,905mn, a reported margin of
to support loan expansion. For the impairment loss of loans was 146.58 million Baht, an increase of 22.68 million Baht or 18.31%. The increase was due to provided normal provision and provided general
borrowing to support loan expansion. For the impairment loss of loans was 114.07 million Baht, a decrease of 32.51 million Baht or 22.18%. The decrease was due to the good improvement of receivables quality
through expansion of customer base and income by providing financial transactions via multiple platforms to offset reduced income after the cancellation of funds transfer fees via digital channels. In
expansion of subsidiaries, staff cost and expenses of hospital quality improvement. Please be informed accordingly. Sincerely yours, (Mr Pongpat Patanavanich) Managing Director
business expansion would not meet the target. 6. Shareholding before transaction: 49.00% of the Registered Capital 7. Shareholding after transaction: 0% of the Registered Capital We are also pleased to
. Finance costs increased by Baht 2.95 million or 18.81 % due to the Investments in subsidiaries and the building expansion projects of the subsidiaries. Sincerely yours, (Mr.Pongpat Patanavanich) Managing
known and the greater customer base expansion resulting in the net profit in accordance with the ratio of stocks held by the Company of 1.04 million baht. The combination of such two incomes results in